Cargando…
Secretory carcinoma of major and minor salivary glands with ETV6-NTRK3 gene fusion: overcoming misdiagnosis in the era of tumour-agnostic therapy with TRK inhibitors
INTRODUCTION: Secretory carcinoma (SC) of the salivary gland is an extraordinarily rare tumour. Accurate diagnosis of SC is crucial for understanding the clinical course, prognosis, and selection of optimal therapy. The aim of this research was to analyse retrospectively the clinical and pathologica...
Autores principales: | Durzyńska, Monika, Dominiak, Karol, Sosnowska, Iwona, Michalek, Irmina Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546963/ https://www.ncbi.nlm.nih.gov/pubmed/37794988 http://dx.doi.org/10.5114/wo.2023.131204 |
Ejemplares similares
-
ETV6–NTRK3-positive parotid mammary analogue secretory carcinoma: a case report
por: Cobo, Juan Rodríguez, et al.
Publicado: (2021) -
Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report
por: Wagner, Florian, et al.
Publicado: (2021) -
Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature
por: Arce, C, et al.
Publicado: (2005) -
TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs
por: Han, Sun-Young
Publicado: (2021) -
NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies
por: Marchetti, Antonio, et al.
Publicado: (2022)